Medical artificial intelligence (AI) company Caption Health has raised $35m in a Series B financing round to develop and commercialise its Food and Drug Administration (FDA)-cleared, AI-guided ultrasound technology.
Led by the company’s existing investor DCVC, the round was joined by new investors Atlantic Bridge and Edwards Lifesciences, along with existing investor Khosla Ventures.
Caption Health plans to use the capital to ramp up its commercial operations and form new partnerships in addition to funding its AI technology platform expansion efforts.
The Caption AI platform, which includes Caption Guidance and Caption Interpretation, is designed to perform ultrasound and obtain diagnostic-quality images.
